 |
|
date |
|
notes |
|
|
|
|
| - S. Tamura and T. Nakamura incorporated Sosei |
|
|
|
|
| - Established globally recognised technology transfer business |
|
|
|
|
| - Mar: Started the Drug Reprofiling Platform®(DRP®) project. |
|
|
|
|
|
- Apr: In-licensed Norlevo® from Laboratoire HRA Pharma.
|
|
|
|
|
|
- Sep: Established Sosei London office.
|
|
|
|
|
| - Nov: Collaboration with EPS
|
|
|
|
|
|
- July: Listed on the MOTHERS index of Tokyo Stock Exchange (code:4565).
|
|
|
|
|
- Mar : Agreed on capital and business alliances with Itochu.
- Aug : Acquisition of Arakis Ltd.(now Sosei R&D Ltd.)
|
|
|
|
|
|
- Oct : Reorganisation under a holding company structure
|
|
|
